M1RN34:BVMF
Moderna Inc Bdr
49,16 R$
0,00%
(0,00) 1D
2 ოქტ, 17:07:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for M1RN34...
Open
49,40 R$
High
50,63 R$
Low
47,98 R$
Mkt. cap
75,86 მლრდ.
Avg. vol.
141,02 ათ.
Volume
85,02 ათ.
52-wk high
54,38 R$
52-wk low
6,02 R$
Shares outstanding
399,24 მლნ.
No. of employees
5 ათ.
Open
49,40 R$
High
50,63 R$
Low
47,98 R$
Mkt. cap
75,86 მლრდ.
Avg. vol.
141,02 ათ.
Volume
85,02 ათ.
52-wk high
54,38 R$
52-wk low
6,02 R$
Shares outstanding
399,24 მლნ.
No. of employees
5 ათ.
News stories
From web sources and news partners
GuruFocus
·
48 წუთის წინ
Moderna (MRNA) Shares Surge on Cancer Vaccine Optimism Despite C
TradingView
·
1 საათის წინ
SA Asks: Is Moderna's stock now a sell after the recent run-up?
Stocktwits
·
16 საათის წინ
SLS, IBRX Stocks Draw Retail Chatter As MRNA Lands A Nasdaq-100 Spot – ‘It Will Be SLS Next’
Simply Wall Street
·
1 დღის წინ
Moderna (MRNA) Stock Looks Too Expensive For Its Sales Story
Profile
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
About Moderna Inc Bdr